US stock customer concentration analysis and revenue diversification assessment for business risk evaluation and investment safety assessment. We identify companies with too much dependency on single customers or concentrated revenue sources that could pose risks. We provide customer analysis, revenue diversification scoring, and concentration risk assessment for comprehensive coverage. Understand business risks with our comprehensive concentration analysis and diversification tools for safer investing.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Most Watched Stocks
TOI - Stock Analysis
4835 Comments
1013 Likes
1
Mazelle
Power User
2 hours ago
This would’ve been perfect a few hours ago.
👍 186
Reply
2
Katiuscia
Power User
5 hours ago
Missed the notice… oof.
👍 118
Reply
3
Dennison
Community Member
1 day ago
This is the kind of thing I’m always late to.
👍 54
Reply
4
Chrstopher
Trusted Reader
1 day ago
I’m taking notes, just in case. 📝
👍 27
Reply
5
Tayeko
Loyal User
2 days ago
You make multitasking look like a magic trick. 🎩✨
👍 85
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.